Marium M Shamaa

5PUBLICATIONS
15CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 13, 2026
Can Carica papaya Serve as an Adjunct to Semaglutide in Mitigating Diabetes-Induced Testicular Injury Through Modulation of Oxidative Stress, Inflammation, Apoptosis, and the miR-34c/miR-155-SIRT1/FOXO1 Axis? An Experimental and Chem-Bio-Informatics Study.

|Jul 28, 2023
The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy-Apoptosis Molecular Crosstalk.

Basant M Salama, Maged W Helmy, Hosny Fouad

|Feb 25, 2023
Chitosan Surface-Modified PLGA Nanoparticles Loaded with Cranberry Powder Extract as a Potential Oral Delivery Platform for Targeting Colon Cancer Cells.

Mona M Mostafa, Maha M Amin, Mohamed Y Zakaria

|Oct 27, 2022
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways.

Heba A S El-Nashar, Haidy Abbas, Mariam Zewail

|Dec 08, 2020
Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins.

Marium M Shamaa

Pageof 1

Frequent Collaborators

1 joint publications

Heba A S El-Nashar

1 joint publications

Haidy Abbas

1 joint publications

Mariam Zewail

1 joint publications

Mohamed A Khattab